Overall rank by patents
#42,280
of 49,997 tracked assignees
USPTO PatentsView assignee record - 6 granted patents across 2 technology areas, recorded in grant years 2015–2020. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).
The verdict
According to USPTO PatentsView, Pelvalon ranks #42,280 of 49,997 tracked US assignees by granted-patent volume, with 6 patents across 2 technology areas.
USPTO PatentsView assignee plate
Corpus R42280 · US Corporation #42,280 · 6 grants
GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-DROP · BOOK-FULL
Nearest grant-volume peer: Pearl Technologies, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Pelvalon · this assignee
27 score
3D Lighting… · lowest
7 score
What this shows Pelvalon's Innovation Score is 26.7/100 (21st percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Pelvalon, Inc. is a focused PatentsView assignee: 2 CPC subclasses with 100% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2018 (2 grants) versus a trough of 1 in 2015. By volume, Pelvalon sits between Pearl Technologies, Inc. and Penny & Giles Controls Limited.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Pearl Technologies, Inc.
6 patents
Peerless Products, Inc.
6 patents
Peking Union Medical College Hospital
6 patents
Pelletron Corporation
6 patents
Pengo Corporation
6 patents
Penguin Automated Systems Inc.
6 patents
Penn Color, Inc.
6 patents
Penny & Giles Controls Limited
6 patents
Pelvalon, Inc.
6 patents
What this shows Pelvalon holds 6 patents at rank #42,357, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #42,357 in granted patent volume.
Other assignees with the most granted patents in Pelvalon's primary technology class.
Pelvalon's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
27 21st percentile higher than 21% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 1 | 16.7% |
| 2016 | 1 | 16.7% |
| 2017 | 1 | 16.7% |
| 2018 | 2 | 33.3% |
| 2020 | 1 | 16.7% |
Top 2 of 2 technology areas
Overall rank by patents
#42,280
of 49,997 tracked assignees
26.7 out of 100
What to do with this data
Pelvalon, Inc.'s patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.